Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications. It also provides specialty chemicals for use in battery chemicals, personal care, agrochemicals, coatings, electronics, and industrial processes; photoresist chemicals to semiconductor applications; electrol. Track Acutaas Chemicals Limited's live NSE:ACUTAAS share price โน3,121.70 (+1.45%), market cap โนโน256B, P/E 89.0. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Basic Materials sector outlook for ACUTAAS โ real-time NSE India stock intelligence.
Acutaas Chemicals Limited
03 August 2026 ยทNSE
Market Cap
โน256B
PE Ratio
89.0
Dividend
5.0%
AI Score
55/100
Open
โน3,100.00
High
โน3,150.70
Low
โน3,025.00
Prev. Close
โน3,077.00
52W High
โน3,740.00
52W Low
โน1,261.20
Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications. It also provides specialty chemicals for use in battery chemicals, personal care, agrochemicals, coatings, electronics, and industrial processes; photoresist chemicals to semiconductor applications; electrol
Key Takeaway
Acutaas Chemicals Limited is rated buy with a P/E of 89.0x โ understand the valuation context before sizing a position.
โ Recommended
Ask AI: Is Acutaas Chemicals Limited fairly valued right now?
Because a P/E of 89.0x needs to be compared against sector peers and growth expectations to be meaningful.
Continue Research
View events affecting Acutaas Chemicals Limited
Because the investment case must account for macro and company-specific developments โ events reveal the 'why' behind price moves.
Trace sector ripple effects
Because Basic Materials moves create upstream and downstream implications that affect the entire thesis.
Intelligence Path
Growth
Govt Exposure
Policy Dependence
Execution Quality
News Sensitivity
Debt Strength
0 Cr
Revenue
0 Cr
Net Profit
0%
ROE
0%
ROCE
35.09
EPS
| โน in Crore | FY22 | FY23 | FY24 | FY25 | TTM |
|---|---|---|---|---|---|
| Revenue | 520 | 613 | 713 | 1,000 | 902 |
| Net Profit | 72 | 83 | 43 | 159 | 214 |
| ROE (%) | โ | โ | โ | 0.0% | 0.0% |
| EPS (โน) | โ | โ | โ | 35.09 | 35.09 |
| Debt/Equity | โ | โ | โ | 2.1 | 2.1 |